• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES Back to Search Results
Catalog Number CDS0705-NTW
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problems Arrhythmia (1721); Atrial Fibrillation (1729); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/20/2022
Event Type  Injury  
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the information reviewed, a cause for the reported arrhythmia and atrial fibrillation cannot be determined.The reported mitral regurgitation is related to patient conditions.Mitral regurgitation, arrhythmia and atrial fibrillation are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.Serious injury/illness/impairment was a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Event Description
This report is being filed due to cardiac arrhythmias requiring future hospitalization and treatment.Patient id: (b)(6).It was reported that on (b)(6) 2021, the patient presented with functional mitral regurgitation (mr), with pure annular dilation, mitral annular calcification.One mitraclip was implanted, reducing the mr to grade 1+.There was no device deficiency.On (b)(6) 2022, a follow-up was performed.Atrial tachycardia along with atrial fibrillation were noted, unknown if device related.Future treatment (ablation) with hospitalization is considered necessary.That same day, a slight increase in mr was noted from the previous echocardiogram, from trace to trace/grade 1+.Per physician, the increase in mr was unrelated to the mitraclip device.There was no tissue injury noted, and no malfunction.No additional information was provided regarding this issue.
 
Event Description
Subsequent to the previous report, the additional, downgrading information was received: on (b)(6) 2023, the patient was hospitalized for the previously reported atrial fibrillation and tachycardia.Ablation was performed as treatment.Per physician, the cardiac arrythmia events, and treatment of, were unrelated to the mitraclip device.The mitraclip remained stable and well seated, without any device related tissue injury.There was no device malfunction.Although this is considered a non-complaint, regulatory reports have already been filed therefore, this will remain reportable.
 
Manufacturer Narrative
Subsequent information was obtained that the reported arrhythmia and atrial fibrillation were unrelated to the device, therefore, these codes were removed.However, since the initial report has already been filed, the event cannot be downgraded.The reported mitral regurgitation, however, is related to patient conditions.Mitral regurgitation is listed in the instructions for use (ifu) as a known possible complication associated with mitraclip procedures.There remains no indication of a product issue with respect to manufacture, design or labeling.H6 health effect - clinical code 1721 and 1729 were removed, h6 health effect - impact code 4614 was removed, h6 medical device problem code 2993 was removed, h6 investigation conclusions code 67 was removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP G4 CLIP DELIVERY SYSTEM
Type of Device
MITRAL VALVE REPAIR DEVICES
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16437213
MDR Text Key310169015
Report Number2135147-2023-00660
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/11/2022
Device Catalogue NumberCDS0705-NTW
Device Lot Number10210U293
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/31/2023
Initial Date FDA Received02/24/2023
Supplement Dates Manufacturer Received03/09/2023
Supplement Dates FDA Received04/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
Patient SexMale
Patient Weight50 KG
-
-